Healthcare
Amgen Inc. (AMGN)
Amgen Inc. stock analysis and opportunity scoring
$426.11
As of Oct 14
↑ +3.21%
Amgen Inc. (AMGN) at a glance
Amgen Inc. (AMGN) is a publicly traded company in the Healthcare - Drug Manufacturers - General sector tracked by MKD Intelligence.
AMGN last traded at $426.11 up 3.21% on the session as of 2026-10-14.
MKD Intelligence assigns AMGN a composite opportunity score of 70 out of 100, indicating favourable conditions across trend, momentum and volume factors.
The risk score for AMGN is 36 out of 100 (moderate), where a higher number means greater expected volatility.
Healthcare sector comparison
AMGN has a composite opportunity score of 70/100, above the 57.9/100 average across 84 tracked Healthcare stocks. ELV leads the sector at 76/100.
Price History
High
$426.11
Low
$375.65
Period
Oct 14 - Sep 11 (24d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win - Fierce Biotech
Fierce Biotech · Sep 22
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win - fiercebiotech.com
fiercebiotech.com · Sep 22
Upcoming Events
Data as of Oct 15
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.